Our Team
We bring different perspectives and expertise, but are united by a commitment to improve the lives of people living with neural injury and disease.
Michael is a neuroscientist with more than 25 years of experience in spinal cord injury, neural plasticity and cell-based repair. His research has focused on understanding and rebuilding the neural circuits controlling motor and respiratory function after spinal cord injury.
Co-Founder & CEO
Co-Founder & Senior Scientific AdvisorLana is a neuroscientist specializing in spinal interneurons and regenerative cell therapies. She pioneered the methods underlying CELLutions Bio's defined spinal interneuron platform and led key preclinical studies demonstrating their therapeutic potential.
Ed Wirth has been at the forefront of translation for cell therapies and spinal cord injury for >30 years. He has served as the CMO for a number of key clinical trials, including Geron (and now Lineage), In Vivo Therapeutics, and Aspen Neuroscience.
Strategic Advisor
Strategic Advisor
Deepak Srivastava is President of the Gladstone Institutes and strongly committed to translating stem cell therapies to treat human injuries and disease. He has years of experience in translation and business development.
Clinical Advisor
Daniel Hoh is a leading spine neurosurgeon, bringing >15 years experience in neurosurgery, with special focus on spinal surgeries and clinical trial involvement.
Translational Advisor
Dennis Bourbeau is a leader in large animal model and human research, translating treatments for people living with spinal cord injury.
PLEX Consultant
Jake Chalfin was a professional jockey who injured his cervical spinal cord during a steeple race. In recent years, he has been an important patient advocate, invested in research, and helped to establish state funding for spinal cord injury research in Pennsylvania (USA).
PLEX Consultant
Perry is Founder and Executive President of the Perry Cross Spinal Research Foundation in Australia. Through his foundation and lived experience with a high cervical spinal cord injury, Perry brings essential translational advice